Kura Oncology (KURA) Operating Income (2010 - 2026)
Kura Oncology (KURA) posted quarterly Operating Income of -$78.8 million for Q1 2026, down 21.82% year-over-year from -$100.8 million in Q1 2025, and down 21.82% quarter-over-quarter from -$64.7 million in Q1 2025.
Kura Oncology (KURA) Operating Income (2010 - 2026) Analysis & Trends
Kura Oncology (KURA) has reported Operating Income for 7 consecutive years, with -$78.8 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Operating Income fell 21.82% year-over-year to -$78.8 million; the TTM figure through Mar 2026 stood at -$143.5 million (down 121.77% YoY), while the FY2025 annual figure was -$303.6 million, down 57.16% from the prior year.
- Operating Income fell to -$78.8 million in Q1 2026 per KURA's latest filing, from -$64.7 million in the prior quarter.
- Across five years, Operating Income topped out at -$64.7 million in Q1 2025 and bottomed at -$78.8 million in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 1.25 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 1.29 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 493.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -505.13 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 325.05 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -3,158.03 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 133.12 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 231.44 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -1.55 Mn |
| 10 | Kura Oncology | 966.11 Mn | 966.11 Mn | 20.63 Mn | -73.01 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -73.01 Mn |
| Mar 31, 2026 | -78.82 Mn |
| Mar 31, 2025 | -64.70 Mn |
| Dec 31, 2014 | -9,762.00 |
| Sep 30, 2014 | -4,764.00 |
| Jun 30, 2014 | -5,242.00 |
| Mar 31, 2014 | -4,138.00 |
| Dec 31, 2013 | -8,087.00 |
| Sep 30, 2013 | -4,475.00 |
| Jun 30, 2013 | -5,456.00 |
| Mar 31, 2013 | -4,716.00 |
| Dec 31, 2012 | -8,376.00 |
| Sep 30, 2012 | -4,728.00 |
| Jun 30, 2012 | -4,996.00 |
| Mar 31, 2012 | -4,241.00 |
| Dec 31, 2011 | -7,976.00 |
| Sep 30, 2011 | -5,360.00 |
| Jun 30, 2011 | -5,837.00 |
| Mar 31, 2011 | -4,266.00 |
| Dec 31, 2010 | -7,214.00 |